Immunoglobulin preparations attenuate organ dysfunction and hemostatic abnormality by suppressing the production of cytokines in lipopolysaccharide- induced disseminated intravascular coagulation in rats

Critical Care Medicine

Volumn 34, Issue 9, 2006, Pages 2421-2425

  Asakura, Hidesaku ^a   Takahashi, Yoko ^a   Kubo, Anna ^a   Ontachi, Yasuo ^a   Hayashi, Tomoe ^a   Omote, Mika ^a   Arahata, Masahisa ^a   Kadohira, Yasuko ^a   Maekawa, Mio ^a   Yamazaki, Masahide ^a   Morishita, Eriko ^a   Takami, Akiyoshi ^a   Yoshida, Tomotaka ^a   Miyamoto, Ken Ichi ^a   Nakao, Shinji ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Cytokines; Disseminated intravascular coagulation; Immunoglobulin

Indexed keywords

ALANINE AMINOTRANSFERASE; CREATININE; CYTOKINE; FIBRIN; IMMUNOGLOBULIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; DISSEMINATED INTRAVASCULAR CLOTTING; DOSE RESPONSE; DRUG EFFECT; GLOMERULUS; HEMOSTASIS; INFUSION; MALE; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RAT;

ALANINE TRANSAMINASE; ANIMALS; CREATININE; DISEASE MODELS, ANIMAL; DISSEMINATED INTRAVASCULAR COAGULATION; FIBRIN; HEMOSTASIS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INTERLEUKIN-6; KIDNEY GLOMERULUS; LIPOPOLYSACCHARIDES; MALE; PROSPECTIVE STUDIES; RATS; RATS, WISTAR; TUMOR NECROSIS FACTORS;

EID: 33747519981     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000230382.38989.4F     Document Type: Article

References (27)

1. Levi M, Ten Cate H: Disseminated intravascular coagulation. N Engl J Med 1999; 341:586-592
2. Toh CH, Dennis M: Disseminated intravascular coagulation: Old disease, new hope. BMJ 2003; 327:974-977
3. Dempfle CE: Coagulopathy of sepsis. Thromb Haemost 2004; 91:213-224
4. Klebanoff SJ, Vadas MA, Harlan JM, et al: Stimulation of neutrophils by tumor necrosis factor. J Immunol 1986; 136:4220-4225
5. van der Poll T, Levi M, Hack CE, et al: Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 1994; 179:1253-1259
6. Samuelsson A, Towers TL, Ravetch JV: Antiinflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 2001; 291:484-486
7. Sharief MK, Ingram DA, Swash M, et al: I.V. immunoglobulin reduces circulating proinflammatory cytokines in Guillain-Barre syndrome. Neurology 1999; 52:1833-1838
8. Gullestad L, Aass H, Fjeld JG, et al: Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure. Circulation 2001; 103:220-225
9. Kishimoto C, Shioji K, Kinoshita M, et al: Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory cytokines and decreased oxidative stress. Int J Cardiol 2003; 91:173-178
10. Simon HU, Spath PJ: IVIG: Mechanisms of action. Allergy 2003; 58:543-552
11. Pelzer H: Determination of human thrombin-antithrombin III complex in human plasma with an enzyme-linked immunosorbent assay. Thromb Haemost 1988; 59:101-106
12. Kawasaki H, Hayashi K, Awai M: Disseminated intravascular coagulation (DIC): Immunohistochemical study of fibrin-related materials (FRMs) in renal tissues. Acta Pathol Jpn 1987; 37:77-84
13. Suffredini AF, Harpel PC, Parrillo JE: Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med 1989; 320:1165-1172
14. Biemond BJ, Levi M, Ten Cate H, et al: Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: Effect of interventions in the cytokine and coagulation cascades. Clin Sci 1995; 88:587-594
15. van der Poll T, Buller HR, ten Cate H, et al: Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 1990; 322:1622-1627
16. Bevilacqua MP, Pober JS, Majeau GR, et al: Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the actions of interleukin 1. Proc Nat Acad Sci U S A 1986; 83:4533-4537
17. Nawroth PP, Stern DM: Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986; 163:740-745
18. Albertson TE, Panacek EA, MacArthur RD, et al., MAB-T88 Sepsis Study Group: Multicenter evaluation of a human monoclonal antibody to Enterobacteriaceae common antigen in patients with Gram-negative sepsis. Crit Care Med 2003; 31:419-427
19. Ohlsson A, Lacy JB: Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. Cochrane Database Syst Rev 2004; 1:CD001239
20. Asakura H, Asamura R, Ontachi Y, et al: Selective inducible nitric oxide synthase inhibition attenuates organ dysfunction and elevated endothelin levels in LPS-induced DIC model rats. J Thromb Haemost 2005; 3:1050-1055
21. Asakura H, Sano Y, Yoshida T, et al: Beneficial effect of low-molecular-weight heparin against lipopolysaccharide-induced disseminated intravascular coagulation in rats is abolished by coadministration of tranexamic acid. Intensive Care Med 2004; 30:1950-1955
22. Asakura H, Asamura R, Ontachi Y, et al: Beneficial effects of urokinase on lipopolysaccharide-induced disseminated intravascular coagulation in rats: Focus on organ function and endothelin levels. Thromb Haemost 2005; 93:724-728
23. Johnson K, Aarden L, Choi Y, et al: The proinflammatory cytokine response to coagulation and endotoxin in whole blood. Blood 1996; 87:5051-5060
24. van der Poll T, Jansen PM, Montegut WJ, et al: Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia. J Immunol 1997; 158:1971-1975
25. Levi M, ten Cate H, Bauer KA, et al: Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest 1994; 93:114-120
26. Rosen FS: Putative mechanisms of the effect of intravenous gamma-globulin. Clin Immunol Immunopathol 1993; 67:S41-S43
27. Gallay P, Heumann D, Le Roy D, et al: Mode of action of anti-lipopolysaccharide-binding protein antibodies for prevention of endotoxemic shock in mice. Proc Natl Acad Sci U S A 1994; 91:7922-7926